Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine premedication in children undergoing tonsillectomy and adenoidectomy
ACTRN12625000041459Phase 4Completed
- Sponsor
- Mother and Child Health Institute of Serbia Dr Vukan Čupić
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in anxiety disorder (2 arms), sponsored by Mother and Child Health Institute of Serbia Dr Vukan Čupić. Primary endpoints: Plasma malondialdehyde level, Plasma nitric oxide level and 4 more. Started Apr 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ACTRN12625000041459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000041459.